Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Diagnosis of Mortality Using Admission CT Perfusion in Severe Traumatic Brain Injury Patients (ACT-TBI Study)

NCT04318665 is registered in ClinicalTrials.gov with University of Manitoba as lead sponsor.

NCT NCT04318665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04318665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Diagnosis of Mortality Using Admission CT Perfusion in Severe Traumatic Brain Injury Patients (ACT-TBI Study)
Lead sponsor
University of Manitoba
Phase
Not applicable
Overall status
Completed
Start date
July 23, 2020
Completion date
August 2, 2023
Enrollment
200 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury